Zentiva’s turnover increased 5.3% in 2012, to RON248 million.
The company posted 2.8% higher sales in 2012, to RON267.9 million, from RON260.6 million during the same period in 2011, while expenditures rose 5.7%, to RON228.9 million.
French pharmaceutical company Sanofi-Aventis owns 74.9% of Zentiva, according to the latest information.
On the Bucharest Stock Exchange Friday, Zentiva’s shares traded at RON0.853 per unit. (EUR1=RON4.3885)